Yeong Shim - Cellumed CEO, Director

049180 Stock  KRW 2,430  148.00  1.44%   

CEO

Shim Yeong Bok is Chief Executive Officer and Director of CELLUMED CO., LTD. Previously, Shim worked for CHONGKUNDANG CO., LTD and another Koreabased company. Shim holds a Bachelor degree in Business Administration from Hanyang University, Korea. since 2010.
Age 51
Tenure 14 years
Phone82 2 2104 0475
Webhttps://www.cellumed.co.kr

Cellumed Management Efficiency

The company has return on total asset (ROA) of 0.0375 % which means that it generated a profit of $0.0375 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 15.1567 %, meaning that it generated $15.1567 on every $100 dollars invested by stockholders. Cellumed's management efficiency ratios could be used to measure how well Cellumed manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.07 B in total debt with debt to equity ratio (D/E) of 59.7, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Cellumed has a current ratio of 1.23, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Cellumed until it has trouble settling it off, either with new capital or with free cash flow. So, Cellumed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cellumed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cellumed to invest in growth at high rates of return. When we think about Cellumed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CEO Age

WonJong KohDB Financial Investment
65
Yin SeoSungdo Engineering Construction
57
Chang KangSungdo Engineering Construction
57
Geon YoonDSC Investment
53
Cellumed Co., Ltd., a biotech company, develops bone graft substitution based on human tissue graft in Korea. The company was founded in 1997 and is headquartered in Seoul, South Korea. CELLUMED is traded on Korean Securities Dealers Automated Quotations in South Korea. Cellumed Co (049180) is traded on KOSDAQ in Korea and employs 78 people.

Management Performance

Cellumed Leadership Team

Elected by the shareholders, the Cellumed's board of directors comprises two types of representatives: Cellumed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cellumed. The board's role is to monitor Cellumed's management team and ensure that shareholders' interests are well served. Cellumed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cellumed's outside directors are responsible for providing unbiased perspectives on the board's policies.
JooWoong Jang, Managing Director
YoungTaek Song, Managing Director
Ji Jung, Managing Director
Dae Seo, Non-Executive Independent Director
Jeong Park, Vice Chairman
JoonBae Kim, Managing Director
YoungBock Shim, Chief Officer
JinSang Jang, Managing Director
Jae Yoo, Director
Yeong Shim, CEO, Director
Yeong Song, Assistant Managing Director
Jeong Kim, Director
Jun Lee, Internal Auditor
Ju Jang, Assistant Managing Director

Cellumed Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cellumed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Thematic Ideas
Explore Investing Ideas  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellumed Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Cellumed information on this page should be used as a complementary analysis to other Cellumed's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Cellumed Stock analysis

When running Cellumed's price analysis, check to measure Cellumed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellumed is operating at the current time. Most of Cellumed's value examination focuses on studying past and present price action to predict the probability of Cellumed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellumed's price. Additionally, you may evaluate how the addition of Cellumed to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Global Correlations
Find global opportunities by holding instruments from different markets
Please note, there is a significant difference between Cellumed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cellumed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellumed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.